Blog

Tilapia peptide alters gut microbiota in mice with anti-obesity effects

It is a draft guidance

07-Jun-2023 - Last updated on 07-Jun-2023 at 14:39 GMT Collagen Powder Private Label

Tilapia peptide alters gut microbiota in mice with anti-obesity effects

Related tags Collagen peptides Prebiotic Gut microbiota anti-obesity Mice

“In this study, we selected a peptide from fish (tilapia) skin that induces significant changes in the intestinal microflora of mice and reduces the Firmicutes/Bacteroidetes​ ratio, which is linked to obesity,” the team of South Korean researchers wrote in the journal Nutrients.​

Given the known associations of gut microbiota dysbiosis with diseases ranging from inflammatory bowel disease, Crohn’s disease, and ulcerative colitis to type 2 diabetes, autoimmune diseases and behavioral disorders, the researchers asserted that “consumption of probiotics or prebiotics has more value as a therapeutic agent than just a nutritional supplement”. 

To this end, they present the study in the context of developing a gut microbiota-based screening strategy to select nutritional supplements as prebiotic medications.                                                            

The study randomly assigned eight-week-old male C57BL/6 mice fed a high-fat diet to one of six different peptide groups (fish collagen, soybean type A, B, and yeast type A, B, C) or a distilled water control group.  Mice consumed 100 μL of their alloted substance by gavage daily over the 10-day study period.

For the gut microbiota analyses, the researchers collected feces on the third and seventh day after peptide treatment and sacrificed the mice on the tenth day to remove their intestines for further investigation. The analysis of fecal samples revealed that Bacteroidetes​ and Firmicutes​ accounted for close to 90% of the total microbiota in all treatment groups.

“Interestingly, compared with the control group, fish collagen-derived peptides significantly decreased the F/B ratio, whereas other peptides did not affect this ratio,” the researchers wrote.

The collagen peptide treatment increased the abundance of Bacteroidetes​ to 64% and decreased Firmicutes​ to 31% in the gut compared with the control group (38% and 54%, respectively). Other increases in specific bacterial taxa detected in the collagen peptide group: Clostridium_sensu_stricto_1, Faecalibaculum, Bacteroides​, and Streptococcus​, known for their anti-obesity effects.  

The researchers noted that since collagen peptide consumption demonstrated significant reduction in the F/B ratio in normal mice, its anti-obesity effect was expected. 

“Early research on the relationship between obesity and gut microbiota established that significant fractions of intestinal Bacteroidetes​ and Firmicutes​ are altered in obese mice compared with those in lean mice,” they wrote.

Beyond the changes to the composition of the gut microbiota, the study found that the alterations led to activation of metabolic pathways, such as polysaccharide degradation and essential amino acid synthesis, which are associated with obesity inhibition.

“[C]ollagen peptide also effectively reduced all obesity signs caused by a high-fat diet, such as abdominal fat accumulation, high blood glucose levels, and weight gain,” the researchers added, specifying that mice in the collagen peptide group gained considerably less weight than mice fed a high-fat diet alone. 

Source: Nutrients​ 2023​, 15(11), 2610 “Collagen Peptide Exerts an Anti-Obesity Effect by Influencing the Firmicutes/Bacteroidetes Ratio in the Gut”​ doi: doi.org/10.3390/nu15112610​ Authors: Ga Hyeon Baek et al.

Copyright - Unless otherwise stated all contents of this web site are © 2023 - William Reed Ltd - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions

Related topics Research Probiotics, Prebiotics & Postbiotics Proteins, peptides, amino acids Gut/digestive health Weight management

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

With 20% of the global population unsatisfied with their blood sugar levels* and 30% willing to improve them in the 12 next months* blood sugar management...

Content provided by Lallemand Health Solutions | 13-Nov-2023 | Data Sheet

Unveiling the newest addition to Lallemand Health Solutions' dosage formats portfolio: the lozenges.

Content provided by Deerland Probiotics & Enzymes | 06-Nov-2023 | Product Brochure

Tilapia peptide alters gut microbiota in mice with anti-obesity effects

Earthworm peptide PreforPro® is a clinically supported prebiotic that supports the growth of healthy bacteria in the gut by utilizing phage technology.